If there is ever an annual follow up CT scan that does not cause me significant anxiety, this year will be the one.

The positive CHMP opinion is based on data from the CABINET Phase III trial, which investigated Cabometyx versus placebo in people living with advanced pNETs or epNETs, whose disease had progressed ...

ENB-guided dye marking accurately localizes multiple pulmonary nodules with no complications, less time, and no ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

Although lung cancer screening is recommended in the U.S. for certain individuals ... Study Unravels the Earliest Cellular Genesis of Lung Adenocarcinoma; Friday, February 23, 2024.

A novel immuno-PET/CT imaging technique has identified and validated a potent biomarker for nasopharyngeal cancer (NPC). The biomarker, CD70, is highly and constantly expressed in NPCs, and ...